These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8185188

  • 1. Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
    Patel S, Chapman KL, Smith AJ, Heald A, Freedman SB.
    Ann N Y Acad Sci; 1994 Mar 23; 713():360-3. PubMed ID: 8185188
    [No Abstract] [Full Text] [Related]

  • 2. CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration.
    Durieux C, Derrien M, Maldonado R, Valverde O, Blommaert A, Fournié-Zaluski MC, Roques BP.
    Ann N Y Acad Sci; 1994 Mar 23; 713():355-7. PubMed ID: 8185186
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding.
    Patel S, Chapman KL, Heald A, Smith AJ, Freedman SB.
    Eur J Pharmacol; 1994 Mar 03; 253(3):237-44. PubMed ID: 8200418
    [Abstract] [Full Text] [Related]

  • 4. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1130-3. PubMed ID: 1996314
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA, Griffin EP, Shankley NP, Black JW.
    Br J Pharmacol; 1999 Mar 15; 126(6):1496-503. PubMed ID: 10217545
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):725-31. PubMed ID: 7910212
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
    Harper EA, Shankley NP, Black JW.
    Br J Pharmacol; 1999 Mar 15; 126(6):1504-12. PubMed ID: 10217546
    [Abstract] [Full Text] [Related]

  • 8. Functional role of brain CCK receptors.
    Woodruff GN, Hill DR, Boden P, Pinnock R, Singh L, Hughes J.
    Neuropeptides; 1991 Jul 15; 19 Suppl():45-56. PubMed ID: 1881532
    [No Abstract] [Full Text] [Related]

  • 9. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
    Beinborn M, Chen C, DeMeo L, McBride EW, Kopin AS.
    Yale J Biol Med; 1998 Jul 15; 71(3-4):337-46. PubMed ID: 10461364
    [Abstract] [Full Text] [Related]

  • 10. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 15; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 11. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM.
    J Med Chem; 1989 Jan 15; 32(1):13-6. PubMed ID: 2909725
    [No Abstract] [Full Text] [Related]

  • 12. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D, Smith GP.
    Physiol Behav; 1998 Aug 15; 65(1):11-4. PubMed ID: 9811359
    [Abstract] [Full Text] [Related]

  • 13. Gastric effects of the CCK-B/gastrin receptor ligand CI-988 in cynomolgus monkeys.
    Dethloff LA, Patmore SJ, Tierney BM, Bestervelt LL, Zandee JC.
    Food Chem Toxicol; 1998 Jan 15; 36(1):61-71. PubMed ID: 9487364
    [Abstract] [Full Text] [Related]

  • 14. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD.
    Mol Pharmacol; 1994 Nov 15; 46(5):943-8. PubMed ID: 7969084
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptor.
    Castro JL, Broughton HB, Russell MG, Rathbone D, Watt AP, Ball RG, Chapman KL, Patel S, Smith AJ, Marshall GR, Matassa VG.
    J Med Chem; 1997 Aug 01; 40(16):2491-501. PubMed ID: 9258356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy.
    Kopin AS, McBride EW, Gordon MC, Quinn SM, Beinborn M.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):11043-8. PubMed ID: 9380756
    [Abstract] [Full Text] [Related]

  • 19. Effect of hypothalamic microinjection and ventricular perfusion of CCK receptor antagonists on gut myoelectrical activity.
    Nitecki S, Harty GJ, Szurszewski JH.
    Ann N Y Acad Sci; 1994 Mar 23; 713():358-9. PubMed ID: 8185187
    [No Abstract] [Full Text] [Related]

  • 20. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P, Delarge J, Pirotte B.
    Curr Med Chem; 1999 Jun 23; 6(6):433-55. PubMed ID: 10213792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.